Laser
Focal/grid laser treatment does not reduce ranibizumab injection frequency for macular edema
Data from the ZIPANGU study showed the use of focal/grid short-pulse laser therapy in patients receiving ranibizumab injections for the treatment of macular edema secondary to branch retinal vein occlusion did not reduce the number of necessary injections compared with patients undergoing ranibizumab monotherapy, according to a presenter at the virtual Association for Research in Vision and Ophthalmology meeting.
Expert shares pearls for using neuromodulators, dermal fillers, lasers
VIDEO: Surgeon presents intelligent, ultrafast femtosecond laser for cataract surgery
PARIS — Pavel Stodulka, MD, PhD, performed the first in-human surgery with a new femtosecond laser for cataract surgery manufactured by the French company Keranova. The laser, which raised great interest at the European Society of Cataract and Refractive Surgeons meeting, fragments the nucleus in 20,000 cubic fragments of 200 µm size in less than 20 seconds and through a sophisticated intelligent technology customizes laser power to the different parts of the lens.